Follow up survey after infusion of a heat-treated factor VII concentrate to untreated patients(virgin cases).

Preparation of factor VII concentrate using CNBr-activated

  Background: Factor VII concentrates are used in patients with congenital or acquired factor VII deficiency or treatment of hemophilia patients with inhibitors. In this research, immunoaffinity chromatography was used to purify factor VII from prothrombin complex (Prothrombin-Proconvertin-Stuart Factor-Antihemophilic Factor B or PPSB) which contains coagulation factors II, VII, IX and X. The a...

Small Pool Heat-treated Intermediate Purity Factor Viii Concentrate

Long-term follow-up of ROM treated cases.

Single dose treatment with Rifampicin, Ofloxacin, Minocycline combination, (referred to as ‘ROM’) for ‘single lesion paucibacillary leprosy’ (or ‘SLBP’ leprosy) was introduced in 1997 on recommendation of the World Health Organisation (WHO), in response to the publication of a multi-centre trial carried out in India. Thousands of patients have been treated with this multidrug therapy (MDT) sinc...

preparation of factor vii concentrate using cnbr-activated

background: factor vii concentrates are used in patients with congenital or acquired factor vii deficiency or treatment of hemophilia patients with inhibitors. in this research, immunoaffinity chromatography was used to purify factor vii from prothrombin complex (prothrombin-proconvertin-stuart factor-antihemophilic factor b or ppsb) which contains coagulation factors ii, vii, ix and x. the aim...

Ocular hypertension--a long-term follow-up of treated and untreated patients.

Sixty-one patients with ocular hypertension (1 17 eyes) were followed up for I to 11 years (average 40 7 months). Ten patients (12 eyes) developed visual field defects and optic disc lesions of glaucomatous type ( 10 2 %). Their average age was lower than the average of the sample, and the defect appeared between 1 and 5 years (average 41 3 months). The risk of developing glaucoma was related t...